We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+26.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$20.8B
AUM Growth
+$4.96B
(+31%)
Cap. Flow
+$1.12B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
27.86%
Holding
1,558
New
230
Increased
644
Reduced
511
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$93.6M |
| 2 |
Humana
HUM
|
+$63.1M |
| 3 |
Amazon
AMZN
|
+$62.2M |
| 4 |
AbbVie
ABBV
|
+$56M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$85.1M |
| 2 |
TJX Companies
TJX
|
+$63.8M |
| 3 |
Starbucks
SBUX
|
+$58.1M |
| 4 |
Cadence Design Systems
CDNS
|
+$56.8M |
| 5 |
American Tower
AMT
|
+$47.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.15% |
| 2 | Healthcare | 14.99% |
| 3 | Consumer Discretionary | 12.14% |
| 4 | Financials | 11.31% |
| 5 | Communication Services | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Ingredion
INGR
$6.63B
| $3.14M | 0.02% |
37,876
| – | – |
|
502
Amkor Technology
AMKR
$14.3B
| $3.13M | 0.02% |
254,590
-11,657
| -4% | -$120K |
|
503
Usana Health Sciences
USNA
$252M
| $3.11M | 0.02% |
42,378
+34,090
| +411% | +$2.67M |
|
504
TriNet
TNET
$3.22B
| $3.1M | 0.01% |
50,865
-225
| -0.4% | -$11.2K |
|
505
Steven Madden
SHOO
$3.46B
| $3.09M | 0.01% |
125,059
-375
| -0.3% | -$8.77K |
|
|
CMA
506
DELISTED
Comerica
CMA
| $3.07M | 0.01% |
80,588
-16,604
| -17% | -$579K |
|
|
SCHW
507
Charles Schwab
SCHW
$190B
| $3.05M | 0.01% |
90,485
+72,671
| +408% | +$2.6M |
|
|
GLDD
508
DELISTED
Great Lakes Dredge & Dock
GLDD
| $3.04M | 0.01% |
328,198
-4,940
| -1% | -$43.2K |
|
509
Flowers Foods
FLO
$1.6B
| $3M | 0.01% |
134,225
+1,500
| +1% | +$33.8K |
|
510
Viavi Solutions
VIAV
$10.6B
| $3M | 0.01% |
235,142
+3,455
| +1% | +$41.4K |
|
511
OSI Systems
OSIS
$3.77B
| $2.98M | 0.01% |
39,948
-175
| -0.4% | -$12.8K |
|
|
MRTX
512
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.97M | 0.01% |
+26,047
| New | +$2.53M |
|
513
Digital Turbine
APPS
$1.53B
| $2.96M | 0.01% |
235,048
+49,181
| +26% | +$343K |
|
|
GTHX
514
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.94M | 0.01% |
121,360
+60,169
| +98% | +$995K |
|
515
Adeia
ADEA
$3.16B
| $2.92M | 0.01% |
748,338
+441,795
| +144% | +$1.67M |
|
|
BDSI
516
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.92M | 0.01% |
669,509
+132,925
| +25% | +$597K |
|
|
FITB
517
Fifth Third Bancorp
FITB
$52.5B
| $2.91M | 0.01% |
150,978
+19,353
| +15% | +$359K |
|
518
Box
BOX
$4.66B
| $2.9M | 0.01% |
139,683
+67,370
| +93% | +$1.18M |
|
519
Kinder Morgan
KMI
$71.4B
| $2.88M | 0.01% |
189,701
+175,011
| +1,191% | +$2.66M |
|
|
BLD
520
DELISTED
TopBuild
BLD
| $2.86M | 0.01% |
25,115
-25
| -0.1% | -$2.5K |
|
|
HZNP
521
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.85M | 0.01% |
51,182
+32,454
| +173% | +$1.39M |
|
|
PDM
522
Piedmont Realty Trust
PDM
$1.2B
| $2.84M | 0.01% |
170,787
-34,287
| -17% | -$572K |
|
523
AeroVironment
AVAV
$9.59B
| $2.81M | 0.01% |
35,308
-435
| -1% | -$28K |
|
524
Upbound Group
UPBD
$1.15B
| $2.81M | 0.01% |
101,089
-21,810
| -18% | -$485K |
|
525
Hanover Insurance
THG
$7.77B
| $2.79M | 0.01% |
27,574
+318
| +1% | +$31.2K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Los Angeles Capital Management held 1,558 positions worth $20.8B, up 31% from $15.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Los Angeles Capital Management deployed $1.12B of net new capital in Q2 2020, opening 230 new positions and adding to 644 existing holdings. Its largest new stake was Workday: 145,773 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Incyte, an estimated $85.1M trimmed.
- Los Angeles Capital Management's largest Q2 2020 buy was Workday: 145,773 shares worth $27.3M.
- Los Angeles Capital Management added most to Meta Platforms (Facebook) in Q2 2020, an estimated $93.6M increase.
- Los Angeles Capital Management's biggest Q2 2020 reduction was Incyte, cutting an estimated $85.1M.
- Los Angeles Capital Management fully exited Raytheon Company in Q2 2020, selling an estimated $4.93M.
- Los Angeles Capital Management's ten largest holdings make up 28% of its $20.8B portfolio in Q2 2020.
- Los Angeles Capital Management opened 230 new positions and closed 111 in Q2 2020.
- Los Angeles Capital Management's portfolio value rose 31% quarter-over-quarter to $20.8B.
Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.